New hope for rare tumor patients: drug trial targets desmoid growths without surgery
NCT ID NCT07170644
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 31 times
Summary
This study tests a drug called nirogacestat in 20 Japanese adults with desmoid tumors (also called aggressive fibromatosis) that are growing. The goal is to see if the drug can shrink or control these non-cancerous but painful tumors. Participants take the drug by mouth, and doctors monitor tumor size and side effects over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DESMOID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Nagoya University Hospital
Nagoya, Aichi-ken, 466-8560, Japan
-
National Cancer Center Hospital
Chuo Ku, Tokyo, 104-0045, Japan
-
Osaka Prefectural Hospital Organization Osaka International Cancer Institute
Osaka, 541-8567, Japan
Conditions
Explore the condition pages connected to this study.